
CAS Name: 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine
Additional Names: 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; LTGTrademarks: Lamictal (GSK)
Percent Composition: C 42.21%, ...
Literature References: Prepn: M. G. Baxter et al., EP 21121 (1981 to Wellcome Foundation); D. A. Sawyer et al., US 4602017 (1986). HPLC determn in plasma: C.-L. Cheng et al., J. Chromatogr. B 817, 199 (2005). Anticonvulsant activity: A. A. Miller et al., Epilepsia 27, 483 (1986). Mechanism of action studies: M. J. Leach et al., ibid. 490; X. Xie, R. M. Hagan, Neuropsychobiology 38, 119 (1998). Series of articles on clinical pharmacology, antiepileptic efficacy and safety: Epilepsia 32, Suppl. 2, S1-S21 (1991). Clinical trial in bipolar depression: J. R. Calabrese et al., J. Clin. Psychiatry 60, 79 (1999). Review of clinical experience in epilepsy: H. Choi, M. J. Morrell, Expert Opin. Pharmacother. 4, 243-251 (2003); in bipolar disorder: Z. Bhagwagar, G. M. Goodwin, Expert Opin. Pharmacother. 6, 1401-1408 (2005).
CAS Name: N-Butyl-N-[2-(diethylamino)ethyl]-1-naphthalenecarboxamide
Additional Names: N-butyl-N-[2-(diethylamino)ethyl]-1-naphthamide; bunaphtide; bunaphtine
Percent Composition: C 77.26%, ...
Literature References: Prepn: M. Giannini, DE 2099894 (1971 to Malesci), C.A. 75, 20222a (1971); M. Giannini et al., Farmaco Ed. Sci. 28, 429 (1973). Pharmacology: A. Ferroni, G. Monticelli, Pharmacol. Res. Commun. 5, 151 (1973). Clinical pharmacokinetics: B. Flouvat et al., Therapie 37, 143 (1982).
CAS Name: 1-[10-[3-[4-(2-Hydroxyethyl)-1-piperazinyl]propyl]-10H-phenothiazin-2-yl]-1-propanone
Additional Names: 10-[3-[4-(2-hydroxyethyl)-1-piperazinyl]propyl]-3-propionylphenothiazine; 2-pro...
Literature References: Prepn: M. H. Sherlock, N. Sperber, US 2985654 (1961 to Schering); R. F. Tislow et al., US 3023146 (1962 to Am. Home Products).
CAS Name: 3,4-Dihydro-2-methoxy-2-methyl-4-phenyl-2H,5H-pyrano[3,2-c][1]benzopyran-5-one
Additional Names: 2-methyl-2-methoxy-4-phenyl-5-oxodihydropyrano[3,2-c][1]benzopyran; 3,4-(2'-methyl-2'-...
Literature References: Prepn: M. Ikawa et al., J. Am. Chem. Soc. 66, 902 (1944); M. A. Stahmann, et al., US 2427579 (1947 to Wisconsin Alumni Res. Found.).
CAS Name: 1-[(2-Cyclohexyl-2-phenyl-1,3-dioxolan-4-yl)methyl]-1-methylpiperidinium iodide
Additional Names: N-methyl-N-[(2-cyclohexyl-2-phenyl-1,3-dioxolan-4-yl)-methyl]piperidinium iodide; 1-(...
Literature References: Prepn: M. Kimura et al., JP 66 6585 (1966 to Toyama), C.A. 65, 7191 (1966); and separation of isomers: I. Saikawa, JP 70 16475 (1970 to Toyama), C.A. 73, 45355t. Stability studies: Shiuchi, Miyazaki, Bunseki Kagaku 18, 455 (1969), C.A. 71, 74097z (1969). Incompatibility studies: Kunita et al., Yakuzaigaku 28, 84 (1968), C.A. 69, 99335x (1968). Anticholinergic activity and acute toxicity: J. Faff et al., Pol. J. Pharmacol. Pharm. 30, 493 (1978). Review: Jpn. Med. Gaz. 8(9), 11 (1971).
CAS Name: (3b,16b,17a,18a,20a)-11,17,18-Trimethoxyyohimban-16-carboxylic acid methyl ester
Additional Names: O-methyl-18-epireserpic acid methyl ester; 18-epi-O-methylreserpic acid methyl ester...
Literature References: Prepn: M. M. Robison et al., Experientia 17, 14 (1961); eidem, J. Am. Chem. Soc. 83, 2694 (1961); R. A. Lucas et al., US 3120532; US 3126390; M. M. Robison, R. A. Lucas, US 3151117 (all 1964 to Ciba); Ziegler, US 3264303 (1966 to Ciba).
CAS Name: 2-Amino-4,5,6,7-tetrahydro-6-(phenylmethyl)thieno[2,3-c]pyridine-3-carboxylic acid ethyl ester
Additional Names: 2-amino-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylic ...
Literature References: Prepn: M. Nakanishi et al., DE 1812404; eidem, US 3563997 (1969, 1971 both to Yoshitomi). Pharmacological studies: M. Nakanishi et al., J. Pharm. Soc. Jpn. 90, 272-334 (1970), C.A. 73, 54504t-54510s (1970); eidem, Arzneim.-Forsch. 20, 998, 1004 (1970); Yakuri to Chiryo 2, 1028 (1974). Protective effect vs carbon tetrachloride hepatotoxicity: H. Yasuda et al., Toxicol. Appl. Pharmacol. 52, 407 (1980).
CAS Name: a-Methyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetic acid
Additional Names: 2-(5H-[1]benzopyrano[2,3-b]pyridin-7-yl)propionic acidTrademarks: Niflan (Yoshitomi)
Percent Composition: ...
Literature References: Prepn: M. Nakanishi et al., DE 2337052; eidem, US 3931205 (1974, 1976 both to Yoshitomi); eidem, Yakugaku Zasshi 96, 99 (1976), C.A. 84, 135515b (1976). Physicochemical properties: M. Nobutoki, Y. Ota, Iyakuhin Kenkyu 7, 200 (1976), C.A. 88, 110468h (1978). Absorption, metabolism, distribution, excretion: Y. Kato et al., Yakuri to Chiryo 4, 1473 (1976), C.A. 88, 130710j (1978). Pharmacological study: Y. Maruyama et al., Nippon Yakurigaku Zasshi 73, 113 (1977), C.A. 88, 276m (1978). Toxicity study: M. Edanaga et al., Iyakuhin Kenkyu 7, 211 (1976), C.A. 88, 131015y (1978).
CAS Name: 1'-[3-(3-Chloro-10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)propyl][1,4'-bipiperidine]-4'-carboxamide
Additional Names: 3-chloro-5-[3-(4-piperidino-4-carbamoylpiperidino)propyl]-10,11-dih...
Literature References: Prepn: M. Nakanishi, C. Tashiro, DE 1905765; eidem, US 3668210 (1969, 1972, both to Yoshitomi); M. Nakanishi et al., J. Med. Chem. 13, 644 (1970). Pharmacology and toxicity: M. Nakanishi et al., Arzneim.-Forsch. 21, 391 (1971). Effect on metabolism of serotonin and catecholamines: M. Nakanishi, M. Setoguchi, ibid. 23, 806 (1973). Metabolism: M. Nakanishi et al., J. Pharm. Soc. Jpn. 91, 1042 (1971). HPLC determn in plasma: K. Hikida et al., Anal. Sci. 6, 367 (1990). Review: Jpn. Med. Gaz. 10(7), 5 (1973).
CAS Name: 1'-[3-(10,11-Dihydro-5H-dibenz[b,f]azepin-5-yl)propyl]-[1,4'-bipiperidine]-4'-carboxamide
Additional Names: 5-[3-(4-piperidino-4-carbamoylpiperidino)propyl]-10,11-dihydro-5H-dibenz[b,...
Literature References: Prepn: M. Nakanishi, T. Munakata, JP 66 6752; GB 1017986; Nakanishi et al., US 3329683 (1966, 1966, 1967 all to Yoshitomi); Nakanishi et al., J. Med. Chem. 13, 644 (1970). Pharmacology: Nakanishi et al., Arzneim.-Forsch. 18, 1435 (1968). Metabolism: Nakanishi et al., J. Pharm. Soc. Jpn. 90, 204 (1970).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
